Spire Wealth Management Gamida Cell Ltd. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$2.22 - $4.47 $122,377 - $246,408	-55,125 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$2.2 - $4.46 $121,275 - $245,857	55,125 New	55,125 $140,000
Q2 2021 Jul 26, 2021	SELL	$5.85 - $8.33 $262,226 - $373,392	-44,825 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$7.8 - $12.43 $349,635 - $557,174	44,825 New	44,825 $354,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.